Stocks · News reference
Nautilus Biotechnology Announces Nature Methods Publication Showing Iterative Mapping Quantified 130 Tau Proteoform Groups; Targets About 20 Proteoform Assays By Mid-2028, AKT1 Oncology Assay Entering Early Access Late 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nautilus Biotechnology shares are trading lower. The company reported Q2 financial results.
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.